Signs and Symptoms of COVID-19
The most common signs and symptoms of COVID-19 include fever (92.8%), cough (69.8%), fatigue, and notably gustatory (88.8%) and olfactory (85.6%) dysfunctions, which are stronger predictors of COVID-19 diagnosis than self-reported fever. 1
Common Symptoms by System
Respiratory Symptoms
- Cough (69.8%)
- Dyspnea/shortness of breath (34.5%)
- Sore throat (5.1%)
- Rhinorrhea (4.0%)
- Pharyngalgia (17.4%)
Systemic Symptoms
- Fever (92.8%)
- Fatigue/malaise
- Myalgia/muscle pain (27.7%)
- Headache (7.2%)
Sensory Disturbances
- Anosmia (loss of smell) (85.6%)
- Ageusia (loss of taste) (88.8%)
Gastrointestinal Symptoms
- Nausea and vomiting
- Diarrhea (6.1%)
- Abdominal pain
- Anorexia/poor appetite 2
Disease Progression and Severity
COVID-19 typically progresses through distinct stages:
- Early Stage (0-4 days): Initial symptoms appear with subpleural ground glass opacities in lower lung lobes
- Progressive Stage (5-8 days): Bilateral distribution of infection with diffuse ground glass opacities
- Peak Stage (9-13 days): Dense consolidation, crazy-paving pattern, and residual parenchymal bands
- Absorption Stage (≥14 days): Gradual resolution and signs of recovery 2
Disease severity can be classified as:
- Mild (81%): Non-pneumonia or mild pneumonia
- Severe (14%): Dyspnea, respiratory frequency ≥30/min, blood oxygen saturation ≤93%, partial pressure of arterial oxygen to fraction of inspired oxygen ratio <300, and/or lung infiltrates >50% within 24-48 hours
- Critical (5%): Respiratory failure, septic shock, and/or multiple organ dysfunction or failure 2, 1
Special Populations
Children
- May present with fever, fatigue, cough, nasal congestion, runny nose, expectoration, diarrhea, and headache
- As disease progresses: dyspnea, cyanosis, malaise, restlessness, poor feeding, reduced activity
- Severe cases: respiratory failure, septic shock, metabolic acidosis, bleeding, and coagulation dysfunction
- Up to 45% of children may be asymptomatic 2
Atypical Presentations
- Neurological manifestations: slurred speech, dizziness, weakness, encephalopathy 3
- Dermatological manifestations: erythematous rashes, urticaria, chicken pox-like lesions 4
- Cardiovascular manifestations: arrhythmias, myocardial injury 2
- Renal manifestations: proteinuria, hematuria, elevated BUN and creatinine 4
Clinical Pearls and Pitfalls
- Important pitfall: Asymptomatic carriers can still transmit the virus, with viral loads similar to symptomatic patients 2
- Red flag symptoms: Fever, myalgia/arthralgia, fatigue, and headache have specificities above 90%, substantially increasing the likelihood of COVID-19 when present 5
- Key diagnostic consideration: Patients may present with non-respiratory symptoms only, particularly gastrointestinal or neurological manifestations, without fever or respiratory symptoms 3
- Incubation period: Ranges from 1-14 days (average 5.2 days) from infection to symptom onset 2
- Transmission risk: An infected individual may spread the disease to approximately 2.2 people on average 2
Early recognition of these diverse signs and symptoms is crucial for prompt diagnosis, isolation, and treatment to reduce morbidity, mortality, and disease transmission.